Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
73.32
-1.53 (-2.04%)
Nov 2, 2026, 4:00 PM EST - Market closed
Tarsus Pharmaceuticals Market Cap
Tarsus Pharmaceuticals has a market cap or net worth of $3.22 billion as of November 2, 2026. It is the 4,863rd most valuable company in the world and the 1,460th biggest in the United States. Its market cap has increased by 10.77% in one year.
Market Cap
3.22B
Enterprise Value
2.86B
1-Year Change
10.77%
Global Rank
Country Rank
#1,460 United States
Category
ChartMarket Cap Chart
Since the IPO on October 16, 2020, Tarsus Pharmaceuticals's market cap has increased from $308.14M to $3.22B, an increase of 944.15%. That is a compound annual growth rate of 47.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 3.22B | -7.43% |
| Dec 31, 2025 | 3.48B | 64.21% |
| Dec 31, 2024 | 2.12B | 215.74% |
| Dec 29, 2023 | 670.37M | 71.44% |
| Dec 30, 2022 | 391.01M | -15.95% |
| Dec 31, 2021 | 465.23M | -44.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AbCellera Biologics | 3.60B |
| Acadia Pharmaceuticals | 3.53B |
| Disc Medicine | 3.49B |
| Viking Therapeutics | 3.42B |
| Parabilis Medicines | 3.37B |
| Celcuity | 3.28B |
| Enliven Therapeutics | 3.27B |
| Dyne Therapeutics | 3.23B |